BeOne Medicines (ONC) Change in Inventory (2017 - 2026)

BeOne Medicines (ONC) has 10 years of Change in Inventory data on file, last reported at $71.8 million in Q1 2026.

• On a quarterly basis, Change in Inventory rose 1901.81% year-over-year to $71.8 million in Q1 2026; TTM through Mar 2026 was $169.0 million, a 236.34% increase from a year earlier, with the FY2025 full-year figure at $93.2 million, up 1.83% from the prior year.
• Change in Inventory for Q1 2026 stood at $71.8 million, up from $70.5 million in the prior quarter.
• Over the last five years, Change in Inventory for ONC reached as high as $88.6 million in Q4 2023 and fell as low as -$23.8 million in Q3 2024.
• Historically, Change in Inventory has averaged $26.7 million across 5 years, with a median of $28.6 million in 2022.
• Across the five-year window, Change in Inventory tumbled 1842.71% in 2024 and soared 1901.81% in 2026, its largest moves.
• Year by year, Change in Inventory stood at -$18.9 million in 2022, then surged by 567.6% to $88.6 million in 2023, then retreated by 10.38% to $79.4 million in 2024, then fell by 11.18% to $70.5 million in 2025, then gained by 1.89% to $71.8 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $71.8 million in Q1 2026, $70.5 million in Q4 2025, and $28.8 million in Q3 2025.